99 related articles for article (PubMed ID: 26564408)
1. Approaches for recombinant human factor IX production in serum-free suspension cultures.
do Amaral RL; de Sousa Bomfim A; de Abreu-Neto MS; Picanço-Castro V; de Sousa Russo EM; Covas DT; Swiech K
Biotechnol Lett; 2016 Mar; 38(3):385-94. PubMed ID: 26564408
[TBL] [Abstract][Full Text] [Related]
2. Human cell lines: A promising alternative for recombinant FIX production.
de Sousa Bomfim A; Cristina Corrêa de Freitas M; Picanço-Castro V; de Abreu Soares Neto M; Swiech K; Tadeu Covas D; Maria de Sousa Russo E
Protein Expr Purif; 2016 May; 121():149-56. PubMed ID: 26802680
[TBL] [Abstract][Full Text] [Related]
3. Pilot production of recombinant human clotting factor IX from transgenic sow milk.
Sun YL; Chang YS; Lin YS; Yen CH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():78-89. PubMed ID: 22578515
[TBL] [Abstract][Full Text] [Related]
4. Comparison of growth and recombinant protein expression in two different insect cell lines in attached and suspension culture.
Taticek RA; Choi C; Phan SE; Palomares LA; Shuler ML
Biotechnol Prog; 2001; 17(4):676-84. PubMed ID: 11485429
[TBL] [Abstract][Full Text] [Related]
5. Stable and high-level production of recombinant Factor IX in human hepatic cell line.
de Castilho Fernandes A; Fontes A; Gonsales N; Swiech K; Picanco-Castro V; Faca S; Covas D
Biotechnol Appl Biochem; 2011; 58(4):243-9. PubMed ID: 21838798
[TBL] [Abstract][Full Text] [Related]
6. Effect of Ca2+ and Mg2+ concentration in culture medium on the activation of recombinant factor IX produced in Chinese hamster ovary cells.
Kim WH; Kim JS; Yoon Y; Lee GM
J Biotechnol; 2009 Jul; 142(3-4):275-8. PubMed ID: 19523499
[TBL] [Abstract][Full Text] [Related]
7. Improved expression of recombinant human factor IX by co-expression of GGCX, VKOR and furin.
Liu J; Jonebring A; Hagström J; Nyström AC; Lövgren A
Protein J; 2014 Apr; 33(2):174-83. PubMed ID: 24567122
[TBL] [Abstract][Full Text] [Related]
8. [Serum-free medium for suspension culture of recombinant Chinese hamster ovary (11G-S) cells].
Liu X; Liu H; Ye L; Li S; Wu B; Wang H; Xie J; Chen Z
Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1116-22. PubMed ID: 21090117
[TBL] [Abstract][Full Text] [Related]
9. Serum-free suspension culturing of human cells: adaptation, growth, and cryopreservation.
Biaggio RT; Abreu-Neto MS; Covas DT; Swiech K
Bioprocess Biosyst Eng; 2015 Aug; 38(8):1495-507. PubMed ID: 25822314
[TBL] [Abstract][Full Text] [Related]
10. Yeast hydrolysate as a low-cost additive to serum-free medium for the production of human thrombopoietin in suspension cultures of Chinese hamster ovary cells.
Sung YH; Lim SW; Chung JY; Lee GM
Appl Microbiol Biotechnol; 2004 Feb; 63(5):527-36. PubMed ID: 12856163
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human factor IX produced from transgenic porcine milk.
Lee MH; Lin YS; Tu CF; Yen CH
Biomed Res Int; 2014; 2014():315375. PubMed ID: 24955355
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of recombinant human factor IX: pharmacokinetic studies in the rat and the dog.
Keith JC; Ferranti TJ; Misra B; Frederick T; Rup B; McCarthy K; Faulkner R; Bush L; Schaub RG
Thromb Haemost; 1995 Jan; 73(1):101-5. PubMed ID: 7740479
[TBL] [Abstract][Full Text] [Related]
13. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells.
Côté J; Garnier A; Massie B; Kamen A
Biotechnol Bioeng; 1998 Sep; 59(5):567-75. PubMed ID: 10099373
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution and pharmacokinetics of transgenic pig-produced recombinant human factor IX (rhFIX) in rats.
Chang CH; Chou TK; Yang CY; Chang TJ; Wu YH; Lee TW
In Vivo; 2008; 22(6):693-7. PubMed ID: 19180993
[TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.
Perot E; Enjolras N; Le Quellec S; Indalecio A; Girard J; Negrier C; Dargaud Y
Thromb Res; 2015 May; 135(5):1017-24. PubMed ID: 25795563
[TBL] [Abstract][Full Text] [Related]
16. Strategies to Suspension Serum-Free Adaptation of Mammalian Cell Lines for Recombinant Glycoprotein Production.
Caron AL; Biaggio RT; Swiech K
Methods Mol Biol; 2018; 1674():75-85. PubMed ID: 28921429
[TBL] [Abstract][Full Text] [Related]
17. Stable production of a human growth hormone antagonist from CHO cells adapted to serum-free suspension culture.
Haldankar R; Kopchick JJ; Ridgway D
Biotechnol Prog; 1999; 15(3):336-46. PubMed ID: 10356250
[TBL] [Abstract][Full Text] [Related]
18. A study of the expression of functional human coagulation factor IX in keratinocytes using a nonviral vector regulated by K14 promoter.
Hosseini SJ; Zomorodipour A; Jalal R; Sabouni F; Ataei F
Appl Biochem Biotechnol; 2010 Nov; 162(6):1599-611. PubMed ID: 20397061
[TBL] [Abstract][Full Text] [Related]
19. A galactopoiesis accordant yield of functional recombinant human factor IX from homozygous transgenic pigs requires a large amount of vitamin K supplementation.
Yen CH; Yang TS; Lin YS; Lee MH; Yu KC; Huang CL; Hsieh HH; Tu CF
Transgenic Res; 2016 Aug; 25(4):545-51. PubMed ID: 27160182
[TBL] [Abstract][Full Text] [Related]
20. Significant differences in integration sites of Moloney murine leukemia virus/Moloney murine sarcoma virus retroviral vector carrying recombinant coagulation factor IX in two human cell lines.
Castilho-Fernandes A; Fontes AM; Abraham KJ; de Freitas MC; da Rosa NG; Picanço-Castro V; de Sousa Russo-Carbolante EM; Covas DT
Biotechnol Lett; 2015 May; 37(5):991-1001. PubMed ID: 25650340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
